Michael Rawlins
| Michael David Rawlins | |
|---|---|
 Sir Michael Rawlins in 2010 | |
| Born | 28 March 1941 |
| Nationality | British |
| Occupation | Chairman of NICE |
| Website | |
| Biography at NICE | |
Sir Michael Rawlins is the chairman of the National Institute for Health and Clinical Excellence (NICE).
Education
Rawlins obtained his undergraduate medical degree at St Thomas' Hospital, graduating in 1965. His post-graduate training in clinical pharmacology and general medicine was completed at St Thomas' and the Hammersmith hospitals, with a year at the Karolinska Institute in Stockholm.[1]
Career
From 1973 to 2006, Rawlins was the Ruth and Lionel Jacobson Professor of Clinical Pharmacology at Newcastle University where he undertook research into the safety and efficacy of new and established pharmacological treatments. At the same time he was consultant physician to the Newcastle University Hospitals where he practised clinical pharmacology and general internal medicine.
He became a member of the Committee on Safety of Medicines in 1980 and served as chairman from 1993 to 1998. He was appointed chairman of the Advisory Council on the Misuse of Drugs in 1998 and served until 2008. Rawlins has been the Chairman of NICE since its formation in 1999.[2] He is currently a member of the Advisory Board of Incentives for Global Health, the not-for-profit behind the Health Impact Fund.
He was appointed Knight Bachelor in 1999 for services to the improvement of patient protection from the side effects of medicinal drugs.
Rawlins has published numerous articles,[3] book chapters,[4] and official publications. He has delivered the Bradshaw (1986), William Withering (1994), Samuel Gee (2006), and Harveian (2008) lectures at the Royal College of Physicians.[5] He was awarded the Hutchinson Medal in 2003, the Galen Medal in 2010, and a Lifetime Achievement Award from the International Society of Pharmacoeconomics and Outcomes Research in 2011.[4] In 2010 he established the All-Party Parliamentary Group for Huntington’s disease in the UK Parliament, chaired by Lord Walton of Detchant and supported by more than 40 MPs and Lords.[6]
In 2012, Rawlins announced his departure from NICE, due in 2013, and became President of the Royal Society of Medicine.[7]
References
- ↑ "Trustees of the DRSU". Drug Safety Research Unit. Retrieved 30 July 2011.
- ↑ "Who we are - Board". NICE website. Retrieved 30 July 2011.
- ↑ "NIH indexed articles authored by M Rawlins". PubMed. Retrieved 30 July 2011.
- ↑ 4.0 4.1 "Prof Sir Michael Rawlins's Biography". Debretts. Retrieved 30 July 2011.
- ↑ "Attack on traditional ways of assessing the evidence of therapeutic interventions". RCP.
- ↑ Rawlins, M (Oct 23, 2010). "Huntington's disease out of the closet?". Lancet 376 (9750): 1372–3. doi:10.1016/S0140-6736(10)60974-9. PMID 20594589.
- ↑ "Leading questions: Sir Michael Rawlins, Royal Society of Medicine". Retrieved 7 February 2013.